You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 88 No. 6, December 1963 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Study of the Galvanic Skin Response in Cystic Fibrosis

DANIEL J. PERRY, MD; GEORGE E. MOUNT, PhD; EDWIN T. WRIGHT, MD

Arch Dermatol. 1963;88(6):742-744.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

In recent years standardization experiments with the galvanic skin response (GSR) have shown a correlation with drug stimulation or suppression of sweat glands.1-5 When sweat-stimulating drugs were used, the skin resistance was lowered and the GSR level rose. Contrarily, when these glands were suppressed by sweat-inhibiting compounds, the resistance was increased and the GSR level fell. These results have been repeatedly observed in normal subjects under varying experimental conditions. The observations suggest the possibility that the GSR level might be effected by abnormal changes in sweat electrolytes. Cystic fibrosis is a disease which is characterized by increased sweat electrolyte concentration.6-8 Therefore, the present study was undertaken to examine the relationship in a series of cystic fibrosis patients.

Materials and Methods

The experimental series consisted of 12 cystic fibrosis patients and 22 controls. The 12 cystic fibrosis subjects varied from 1-16 in age (average 9.5) including five males . . . [Full Text PDF of this Article]


Author Affiliations

LOS ANGELES

Division of Dermatology, Department of Medicine, University of California at Los Angeles and Medical Service, Veterans Administration Center, General Medical and Surgical Service Hospital (Drs. Perry and Wright); Departments of Psychology and Engineering, University of California at Los Angeles (Dr. Mount).


Footnotes

This study was aided by a grant from the G. D. Searle & Co., Chicago.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.